Autonomic Therapies in Atrial Fibrillation
Clayton Wiggins Background: Atrial fibrillation (AF) is the most common pathological arrhythmia in the United States, with its prevalence expected to grow to 12.1 million people by 2030. Despite the pressing need to address this disease, current therapies fall short for preventing disease progression for many patients1. There is growing…